Below are the most recent publications written about "Marfan Syndrome" by people in Profiles.
-
MacCarrick G, Afifi RO, Allen R, Almpani K, Black JH, Boyce AM, Braverman AC, Cameron DE, Caplan J, Cervi E, Cha MJ, Christensen J, van de Laar IM, Demo E, Dewals W, Doyle AJ, Doyle JJ, Fischbein MP, Fleischer J, Fleischman F, Frischmeyer-Guerrerio PA, Guerrerio AL, Huguenard AL, Jani PH, Jordan CP, Kim HJ, Krebsová A, Kockova R, Lee JS, Lobner K, Narula N, Niknahad A, Neptune E, Pedroza AJ, Perry M, Richer J, Rios-Sanchez J, Roman MJ, Russo M, Schweber J, Shalhub S, Sorber R, Speed T, Sponseller PD, Vincent TL, Whelan A, Zeiler SR, Loeys B, Dietz HC. Loeys-Dietz syndrome: 2026 updated care management primer. Genet Med. 2026 07; 28(7):102577.
-
Whelan AR, Thorsen MM, MacCarrick G, Russo ML. Cardiovascular and obstetrical outcomes among delivering patients with Marfan or Loeys-Dietz syndrome: a retrospective analysis by hospital delivery setting. Am J Obstet Gynecol MFM. 2024 04; 6(4):101340.
-
Senser EM, Misra S, Henkin S. Thoracic Aortic Aneurysm: A Clinical Review. Cardiol Clin. 2021 Nov; 39(4):505-515.
-
Balsam LB, Hoffman WD. Commentary: The unacceptable aortic risk with fluoroquinolone exposure in Marfan syndrome. J Thorac Cardiovasc Surg. 2022 03; 163(3):e227-e228.
-
Balsam LB. Commentary: Management of the aortic arch in Loeys-Dietz and Marfan syndromes. J Thorac Cardiovasc Surg. 2020 11; 160(5):1179-1180.
-
Walji TA, Turecamo SE, DeMarsilis AJ, Sakai LY, Mecham RP, Craft CS. Characterization of metabolic health in mouse models of fibrillin-1 perturbation. Matrix Biol. 2016 09; 55:63-76.
-
Braverman AC, Harris KM, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015 Dec 01; 132(22):e303-9.
-
Braverman AC, Harris KM, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 01; 66(21):2398-2405.
-
Maron BJ. Historical Perspectives on Sudden Deaths in Young Athletes With Evolution over 35 Years. Am J Cardiol. 2015 Nov 01; 116(9):1461-8.
-
Lally DR, Monsonego J. Images in clinical medicine. Ectopia lentis in Marfan's syndrome. N Engl J Med. 2014 Nov 06; 371(19):e28.